Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Adalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis.

Metyas SK, Tadros RM, Arkfeld DG.

Rheumatol Int. 2009 Feb;29(4):437-9. doi: 10.1007/s00296-008-0691-8. Epub 2008 Sep 2.

PMID:
18762943
2.

Sarcoid-like granulomatosis in patients treated with anti-TNFα factors. A case report and review of the literature.

Kanellopoulou T, Filiotou A, Kranidioti H, Dourakis SP.

Clin Rheumatol. 2011 Apr;30(4):581-3. doi: 10.1007/s10067-010-1603-3. Epub 2010 Oct 23. Review.

PMID:
20972592
3.

Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case series.

Toussirot E, Berthelot JM, Pertuiset E, Bouvard B, Gaudin P, Wendling D, le Noach J, Lohse A, Lecuyer E, Cri L.

J Rheumatol. 2009 Nov;36(11):2421-7. doi: 10.3899/jrheum.090030. Epub 2009 Oct 1.

PMID:
19797509
4.

Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new "class effect" paradoxical phenomenon. Two case reports and literature review.

Massara A, Cavazzini L, La Corte R, Trotta F.

Semin Arthritis Rheum. 2010 Feb;39(4):313-9. doi: 10.1016/j.semarthrit.2008.11.003. Epub 2009 Jan 15. Review.

PMID:
19147181
6.

New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication.

Tong D, Manolios N, Howe G, Spencer D.

Intern Med J. 2012 Jan;42(1):89-94.

PMID:
22389903
7.

Palisaded neutrophilic and granulomatous dermatitis presenting in a patient with rheumatoid arthritis on adalimumab.

Stephenson SR, Campbell SM, Drew GS, Magro CM.

J Cutan Pathol. 2011 Aug;38(8):644-8. doi: 10.1111/j.1600-0560.2011.01716.x. Epub 2011 May 19.

PMID:
21592182
8.

Adalimumab, etanercept, and infliximab utilization patterns and drug costs among rheumatoid arthritis patients.

Carter CT, Changolkar AK, Scott McKenzie R.

J Med Econ. 2012;15(2):332-9. doi: 10.3111/13696998.2011.649325. Epub 2012 Jan 6.

PMID:
22168788
9.

Tumor necrosis factor-alpha antagonist-induced sarcoidosis.

Clementine RR, Lyman J, Zakem J, Mallepalli J, Lindsey S, Quinet R.

J Clin Rheumatol. 2010 Sep;16(6):274-9. doi: 10.1097/RHU.0b013e3181efa190.

PMID:
20808167
10.

Cytokine production from stimulated whole blood cultures in rheumatoid arthritis patients treated with various TNF blocking agents.

Popa C, Barrera P, Joosten LA, van Riel PL, Kullberg BJ, van der Meer JW, Netea MG.

Eur Cytokine Netw. 2009 Jun;20(2):88-93. doi: 10.1684/ecn.2009.0150.

11.

Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.

Dewedar AM, Shalaby MA, Al-Homaid S, Mahfouz AM, Shams OA, Fathy A.

Int J Rheum Dis. 2012 Jun;15(3):330-5. doi: 10.1111/j.1756-185X.2012.01715.x. Epub 2012 Feb 13.

PMID:
22709496
12.

Differences in annual medication costs and rates of dosage increase between tumor necrosis factor-antagonist therapies for rheumatoid arthritis in a managed care population.

Ollendorf DA, Klingman D, Hazard E, Ray S.

Clin Ther. 2009 Apr;31(4):825-35. doi: 10.1016/j.clinthera.2009.04.002.

PMID:
19446156
13.

Persistence with anti-tumor necrosis factor therapies in patients with rheumatoid arthritis: observations from the RADIUS registry.

Markenson JA, Gibofsky A, Palmer WR, Keystone EC, Schiff MH, Feng J, Baumgartner SW.

J Rheumatol. 2011 Jul;38(7):1273-81. doi: 10.3899/jrheum.101142. Epub 2011 May 15.

PMID:
21572150
14.

Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors.

Deng A, Harvey V, Sina B, Strobel D, Badros A, Junkins-Hopkins JM, Samuels A, Oghilikhan M, Gaspari A.

Arch Dermatol. 2006 Feb;142(2):198-202.

PMID:
16490847
16.
17.

[Fully human anti TNF-alpha monoclonal antibodies (adalimumab, golimumab)].

Hirohata S.

Nihon Rinsho. 2007 Jul;65(7):1202-8. Review. Japanese.

PMID:
17642233
18.

Adalimumab: new preparation. Rheumatoid arthritis: no therapeutic advance.

[No authors listed]

Prescrire Int. 2004 Oct;13(73):171-5.

PMID:
15499697
19.

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.

Hetland ML, Christensen IJ, Tarp U, Dreyer L, Hansen A, Hansen IT, Kollerup G, Linde L, Lindegaard HM, Poulsen UE, Schlemmer A, Jensen DV, Jensen S, Hostenkamp G, Østergaard M; All Departments of Rheumatology in Denmark.

Arthritis Rheum. 2010 Jan;62(1):22-32. doi: 10.1002/art.27227.

20.

Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases.

Toussirot E, Pertuiset E, Kantelip B, Wendling D.

Clin Exp Rheumatol. 2008 May-Jun;26(3):471-5. Review.

PMID:
18578973

Supplemental Content

Support Center